Lyell Immunopharma
0 followers
Lyell is an immuno-oncology company dedicated to reprogramming T cells to achieve curative therapies for solid tumors. The company takes a deliberate approach to solving what it believes to be the major barriers to successful adoptive T cell therapy: T cell exhaustion and loss of durable stemness, w... Read more
Org chart
Lynn Seely
President & CEO
Lynn Seely
Collapse
Tina Albertson
Chief Medical Officer & Head of Development
Stephen Hill
Chief Operating Officer
Gary Lee
Chief Scientific Officer
Charles Newton
Chief Financial Officer
Matthew Lang
Chief Business Officer
Ellen Rose
SVP, Investor Relations & Communications
Joseph Maguire
Head Of GMP Automation And Data
Eric Hoffmann
Staff Software Engineer, Devsecops
Erik Green
Senior Software Engineer Ii, Devsecops
Marly Puckett
Software Engineer
Senai Teklemichael
Senior Devsecops Engineer
Cynthia Shumate
Senior Director, IP
Jennifer Fleischer
Senior Director, IP
Julie Urvater
Senior Director, Intellectual Property
Stasiu Nowak
Director, Intellectual Property
Manjit Dokal
Director, ERP Systems
Chris Michon
Associate Director, IT Operations
Pradeep Ravindra
Associate Director, Data Analytics, Manufacturing
Artem Yankov
Senior Software Engineer
Danielle Kulman
Associate Director, Total Rewards
Alisha Lewis
Senior Director People Partner
Dana Langworthy
Associate Director Of Talent Acquisition
Julie Jeffery
Associate Director | Talent Acquisition
Karen Duffy-Simons
Director, Talent Practice Leader
Kimberly Henson
Director, Contracts And Legal Services
Joanna Karas
Executive Administrative Assistant
